physostigmine has been researched along with Flushing in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arvat, E; Bellone, J; Boffano, G; Camanni, F; Ghigo, E; Maccario, M; Mazza, E; Müller, EE; Procopio, M; Valetto, M | 1 |
1 other study(ies) available for physostigmine and Flushing
| Article | Year |
|---|---|
Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans.
Topics: Adult; Bethanechol Compounds; Cholinergic Antagonists; Cholinesterase Inhibitors; Female; Flushing; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Injections, Intravenous; Male; Neostigmine; Physostigmine; Pyridostigmine Bromide; Receptors, Cholinergic | 1994 |